Dawaa Reference

chronic

Pharyngeal (Throat) Cancer

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class DD28.03 - condition scope only, no dose · NICE NG12: Suspected cancer: recognition and referral (recommendation 1.2) - https://www.ncbi.nlm.nih.gov/books/NBK555330/ · No dose - referral pathway, no medicine given in primary care

Verified against2 documents
  • No dose - referral pathway, no medicine given in primary care
  • Pharyngeal (Throat) Cancer - disease-level clinical article (pharyngeal-cancer-full.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (3)

  • A painless neck lump is often the first sign, and any new neck mass lasting over 2 weeks in an adult should be presumed cancer until proven otherwise [neck lump]
  • Hoarseness, painful or difficult swallowing, ear pain, one-sided nasal blockage, nosebleeds, vision changes, or persistent facial pain should raise suspicion [blocked nose · ear pain · facial pain · hoarseness · nosebleed]
  • Asian ancestry, heavy tobacco or alcohol use, and a prior head and neck or skin cancer are relevant risk history

Signs — what you find (3)

  • A one-sided middle ear effusion in an adult can signal a blocking mass in the nasopharynx
  • Enlarged or lopsided adenoid tissue found in an adult, rather than a child, is a worrying finding
  • Cranial nerve testing is essential to catch any deficit or asymmetry pointing to tumor spread

Tests (5)

  • CT with contrast is best for bone invasion and lymph node staging but is less accurate for very small tumors or soft tissue extent
  • MRI is the most precise study for local tumor extent and can catch subclinical tumors that endoscopy and CT scans miss
  • A PET scan is recommended to look for distant spread and subclinical lymph node involvement
  • A neck node that tests positive for EBV can be assumed to come from a nasopharyngeal primary even if no tumor is visible
  • Biopsy of the mass, or needle sampling of an involved neck node when no primary is visible, confirms the histologic diagnosis

If not this — what else fits (2)

  • Enlarged adenoids or HIV-related lymphoid hyperplasia, an antrochoanal polyp, or an inverting papilloma can mimic a nasopharyngeal mass
  • Infectious mononucleosis and non-Hodgkin lymphoma are also on the differential for a neck mass with these symptoms

SourceStatPearls "Nasopharyngeal Cancer" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Cancer of the pharynx, less commonly encountered in Egyptian primary care than other regional cancers. GP recognises persistent throat symptoms, especially in smokers, and refers urgently to ENT/oncology. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Cancer of the pharynx, less commonly encountered in Egyptian primary care than other regional cancers. GP recognises persistent throat symptoms, especially in smokers, and refers urgently to ENT/oncology.

Cautions
  • RED FLAG - Acute airway obstruction or stridor secondary to expanding pharyngeal mass: assess urgently and refer.
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - In adults, any new neck mass persisting for more than 2 weeks must be presumed malignant until proven otherwise and referred.
  • RED FLAG - Unilateral middle ear effusion in an adult should raise suspicion for nasopharyngeal obstruction/cancer.
  • RED FLAG - Hoarseness or sore throat persisting more than 3 weeks, a one-sided neck lump, difficulty swallowing, unexplained weight loss, or ear pain with no ear cause found.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.